IDEAS home Printed from https://ideas.repec.org/a/bla/biomet/v60y2004i2p482-490.html
   My bibliography  Save this article

Adaptive Two-Stage Designs for Single-Arm Phase IIA Cancer Clinical Trials

Author

Listed:
  • Yong Lin
  • Weichung J. Shih

Abstract

No abstract is available for this item.

Suggested Citation

  • Yong Lin & Weichung J. Shih, 2004. "Adaptive Two-Stage Designs for Single-Arm Phase IIA Cancer Clinical Trials," Biometrics, The International Biometric Society, vol. 60(2), pages 482-490, June.
    • Handle: RePEc:bla:biomet:v:60:y:2004:i:2:p:482-490
    as

    Download full text from publisher

    File URL: http://hdl.handle.net/10.1111/j.0006-341X.2004.00193.x
    Download Restriction: Access to full text is restricted to subscribers.
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Lingfang Xia & Qi Zhou & Yunong Gao & Wenjing Hu & Ge Lou & Hong Sun & Jianqing Zhu & Jin Shu & Xianfeng Zhou & Rong Sun & Xiaohua Wu, 2022. "A multicenter phase 2 trial of camrelizumab plus famitinib for women with recurrent or metastatic cervical squamous cell carcinoma," Nature Communications, Nature, vol. 13(1), pages 1-9, December.
    2. Cornelia U. Kunz & Meinhard Kieser, 2011. "Simon's minimax and optimal and Jung's admissible two-stage designs with or without curtailment," Stata Journal, StataCorp LP, vol. 11(2), pages 240-254, June.
    3. Sambucini, Valeria, 2019. "Bayesian predictive monitoring with bivariate binary outcomes in phase II clinical trials," Computational Statistics & Data Analysis, Elsevier, vol. 132(C), pages 18-30.
    4. Kim, Seongho & Wong, Weng Kee, 2022. "Spatial two-stage designs for phase II clinical trials," Computational Statistics & Data Analysis, Elsevier, vol. 169(C).
    5. Stefan Englert & Meinhard Kieser, 2012. "Improving the Flexibility and Efficiency of Phase II Designs for Oncology Trials," Biometrics, The International Biometric Society, vol. 68(3), pages 886-892, September.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:bla:biomet:v:60:y:2004:i:2:p:482-490. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Wiley Content Delivery (email available below). General contact details of provider: http://www.blackwellpublishing.com/journal.asp?ref=0006-341X .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.